FDA approves 1st Lyrica generics

The FDA has approved several new generics of Lyrica, a brand-name drug manufactured by Pfizer to treat fibromyalgia, nerve pain and partial onset seizures in patients 17 years of age and older. They are the first FDA-approved generics for the drug.

The agency OK'd generic versions of Lyrica, pregabalin, to Alembic Pharmaceuticals, Alkem Laboratories, Amneal Pharmaceuticals, Dr. Reddy’s Laboratories, InvaGen Pharmaceuticals, MSN Laboratories, Rising Pharmaceuticals, Sciegen Pharmaceuticals and Teva Pharmaceuticals.

"Today's approval of the first generics for pregabalin, a widely used medication, is another example of the FDA's long-standing commitment to advance patient access to lower cost, high quality generic medicines," said Janet Woodcock, MD, director of the FDA's Center for Drug Evaluation and Research.

More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
Publix Pharmacy to deliver prescriptions to patients before hospital discharge

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars